COMPPARE Connection: Fall 2020

FALL 2020

A Message from Dr. Nancy Mendenhall

Despite the challenges that we and other cancer research studies continue to face in this unprecedented time of COVID-19, COMPPARE has made significant progress toward our ultimate goal of helping prostate cancer patients.

COMPPARE Enrolls 750 Patients

The COMPPARE team was pleased to announce in August that the study had enrolled 750 patients, 25% of its 3,000-patient goal.

COMPPARE Consortium Spotlight: The James M. Slater Center

Jerry D. Slater, MD, Medical Director of the James M. Slater, MD Proton Treatment & Research Center discusses how the center increased COMPPARE patient enrollment, retention, and team engagement.

Putting Prostate Cancer Awareness into Action

September is Prostate Cancer Awareness Month, but how well do awareness and promotion work when it comes to the target audience? As it turns out, actions may speak louder than words.

Lights, Camera, Action: Calvin Minor

As co-star of COMPPARE’s recruitment video with his son Tarik (both shown right), Calvin is a committed patient advocate who believes in the work of the study’s team.

Our Health, Our Voice Information Session

Our Health, Our Voice Live Information Session November 4

Dr. Nancy Mendenhall will participate in "Our Health, Our Voice: Improving Prostate Cancer Outcomes through Participation in Research" on November 4, 2020.

Your Community: PSA Screening

More widespread PSA screening would reduce mortality rates and BOB Tales wants to get the word out.

Study Progress

Want the latest information on COMPPARE? Find out how many patients have enrolled and how many sites are currently enrolling patients on the COMPPARE Study Progress page.

Research reported in this newsletter was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). The views, statements, and opinions presented in this newsletter are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee.

To manage your subscription, or safely opt-out, email comppare-admin@ufl.edu.